Home/Biodesix/Dr. James Jett
DJ

Dr. James Jett

Co-Chief Medical Officer

Biodesix

Biodesix Pipeline

DrugIndicationPhase
Nodify Lung® Tests (XL2 & CDT)Risk assessment of indeterminate pulmonary nodulesCommercial
GeneStrat® (ddPCR & NGS)Detection of actionable genomic alterations in advanced lung cancerCommercial
VeriStrat®Prognostic assessment in lung cancerCommercial
Drug Candidate 1Oncology (Likely Lung Cancer)Undisclosed Preclinical/Discovery
Drug Candidate 2Oncology (Likely Lung Cancer)Undisclosed Preclinical/Discovery
Drug Candidate 3Oncology (Likely Lung Cancer)Undisclosed Preclinical/Discovery